Could a common diabetes drug help aging MS patients?
NCT ID NCT06463743
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 29 times
Summary
This study tests whether metformin, a common diabetes medication, is safe and can protect the brain in people aged 55-75 with multiple sclerosis (MS). Participants will take metformin or a placebo for 9 months, and researchers will use MRI scans to measure nerve health. The goal is to see if metformin can slow age- and MS-related damage, potentially improving disability outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UBMD Neurolgy
RECRUITINGBuffalo, New York, 14203, United States
Conditions
Explore the condition pages connected to this study.